1. Home
  2. REX vs EOLS Comparison

REX vs EOLS Comparison

Compare REX & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REX
  • EOLS
  • Stock Information
  • Founded
  • REX 1980
  • EOLS 2012
  • Country
  • REX United States
  • EOLS United States
  • Employees
  • REX N/A
  • EOLS N/A
  • Industry
  • REX Major Chemicals
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • REX Industrials
  • EOLS Health Care
  • Exchange
  • REX Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • REX 800.0M
  • EOLS 702.2M
  • IPO Year
  • REX N/A
  • EOLS 2018
  • Fundamental
  • Price
  • REX $41.44
  • EOLS $13.48
  • Analyst Decision
  • REX Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • REX 1
  • EOLS 6
  • Target Price
  • REX $55.00
  • EOLS $22.60
  • AVG Volume (30 Days)
  • REX 200.0K
  • EOLS 695.8K
  • Earning Date
  • REX 12-03-2024
  • EOLS 03-06-2025
  • Dividend Yield
  • REX N/A
  • EOLS N/A
  • EPS Growth
  • REX 37.28
  • EOLS N/A
  • EPS
  • REX 3.82
  • EOLS N/A
  • Revenue
  • REX $671,877,000.00
  • EOLS $248,326,000.00
  • Revenue This Year
  • REX N/A
  • EOLS $33.43
  • Revenue Next Year
  • REX $8.80
  • EOLS $32.44
  • P/E Ratio
  • REX $10.86
  • EOLS N/A
  • Revenue Growth
  • REX N/A
  • EOLS 34.42
  • 52 Week Low
  • REX $39.02
  • EOLS $9.25
  • 52 Week High
  • REX $60.79
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • REX 43.22
  • EOLS 67.23
  • Support Level
  • REX $41.33
  • EOLS $9.25
  • Resistance Level
  • REX $43.12
  • EOLS $11.66
  • Average True Range (ATR)
  • REX 1.02
  • EOLS 0.63
  • MACD
  • REX -0.03
  • EOLS 0.27
  • Stochastic Oscillator
  • REX 11.54
  • EOLS 80.73

About REX REX American Resources Corporation

REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: